Our study not only validates the importance of Jag2 in PAH but also provides new mechanistic insights, supporting the Jag2/NOX2/ROS pathway as a potential therapeutic target for PAH.42, 48. This evidence concerns the gene JAG2 and pulmonary arterial hypertension.